Quality & complianceOfficial

FDA lists Class II recall of Victory Medical Center Pharmacy tirzepatide/B6 vials

🇺🇸 FDA enforcement report · Wed 11 Nov 2026

The pharmacy's tirzepatide/B6 multi-dose vial is recalled over a lack of processing controls, with distribution in Colorado, Florida and Texas, according to the FDA enforcement report.

The US Food and Drug Administration has classified a Class II drug recall of TIRZEPATIDE/B6 (MDV) 25MG/10MG/ML 8ML from Victory Medical Center Pharmacy. The entry appears in the agency's enforcement report dated 11 November 2026 under recall number D-0148-2027.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Official source: FDA enforcement report ↗

Article written by VigiEye from the official source (FDA enforcement report). AI-assisted; check the source before acting.